Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Jones

Showing results (191-200 of 363) with videos related to

Pageof 37
Sort By:
International Journal of Laboratory Hematology|July 24, 2018
Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin timeSteve Kitchen, Ulrich Geisen, Janos Kappelmayer, et al.
Trials|April 21, 2020
ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancerBen Fulton, Robert Jones, Thomas Powles, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
The modular nature of long-association pathways in the human brainChiara Maffei, Marina R Celestine, Ting Gong, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 25, 2008
A blueprint for radioanalytical metrology CRMs, intercomparisons, and PEKenneth G W Inn, Hiromu Kurosaki, Carole Frechou, et al.
Pilot and Feasibility Studies|December 15, 2016
Can a mindfulness-informed intervention reduce aggressive behaviour in people with intellectual disabilities? Protocol for a feasibility studyGemma Maria Griffith, Robert Jones, Richard Patrick Hastings, et al.
Environmental Research|February 15, 2020
Characterization of trace elements exposure in pregnant women in the United States, NHANES 1999-2016Christina Vaughan Watson, Michael Lewin, Angela Ragin-Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2023
Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trialKarim Fizazi, Neal D Shore, Matthew Smith, et al.
European Urology Oncology|June 26, 2026
Adjusted Comparison of First-line Enfortumab Vedotin Plus Pembrolizumab Versus Platinum-based Chemotherapy ± Avelumab Maintenance for the Treatment of Locally Advanced/Metastatic Urothelial CarcinomaRyan Dillon, Robert Jones, Aude Fléchon, et al.
Malaria Journal|August 13, 2009
Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacyFrancis W Hombhanje, David Linge, Adolf Saweri, et al.
Investigational New Drugs|April 30, 2013
Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II studyTim Eisen, Yaroslav Shparyk, Nicholas Macleod, et al.
Pageof 37

Showing results (191-200 of 363) with videos related to

Sort By:
Pageof 37
International Journal of Laboratory Hematology|July 24, 2018
Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin timeSteve Kitchen, Ulrich Geisen, Janos Kappelmayer, et al.
Trials|April 21, 2020
ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancerBen Fulton, Robert Jones, Thomas Powles, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
The modular nature of long-association pathways in the human brainChiara Maffei, Marina R Celestine, Ting Gong, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 25, 2008
A blueprint for radioanalytical metrology CRMs, intercomparisons, and PEKenneth G W Inn, Hiromu Kurosaki, Carole Frechou, et al.
Pilot and Feasibility Studies|December 15, 2016
Can a mindfulness-informed intervention reduce aggressive behaviour in people with intellectual disabilities? Protocol for a feasibility studyGemma Maria Griffith, Robert Jones, Richard Patrick Hastings, et al.
Environmental Research|February 15, 2020
Characterization of trace elements exposure in pregnant women in the United States, NHANES 1999-2016Christina Vaughan Watson, Michael Lewin, Angela Ragin-Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2023
Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trialKarim Fizazi, Neal D Shore, Matthew Smith, et al.
European Urology Oncology|June 26, 2026
Adjusted Comparison of First-line Enfortumab Vedotin Plus Pembrolizumab Versus Platinum-based Chemotherapy ± Avelumab Maintenance for the Treatment of Locally Advanced/Metastatic Urothelial CarcinomaRyan Dillon, Robert Jones, Aude Fléchon, et al.
Malaria Journal|August 13, 2009
Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacyFrancis W Hombhanje, David Linge, Adolf Saweri, et al.
Investigational New Drugs|April 30, 2013
Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II studyTim Eisen, Yaroslav Shparyk, Nicholas Macleod, et al.
Pageof 37